UNH Days sales outstanding
Days sales outstanding at UnitedHealth Group fell to 18.8 days in fiscal 2025, from 20.4 days in 2024.
Year-end receivables divided by total revenue, times 365. Both inputs as filed.
SOURCE: us-gaap:AccountsReceivableNetCurrent + us-gaap:Revenues · EDGAR CompanyFacts · CIK 731766 · EDGAR ↗ · FY2021–FY2025 · ANNUAL
History AS FILED · DERIVATION SHOWN WHERE DERIVED
| Fiscal year | Receivables | Revenue | DSO |
|---|---|---|---|
| FY2025 | $23.0B | $447.6B | 18.8 days |
| FY2024 | $22.4B | $400.3B | 20.4 days |
| FY2023 | $21.3B | $371.6B | 20.9 days |
| FY2022 | $17.7B | $324.2B | 19.9 days |
| FY2021 | $14.2B | $287.6B | 18.0 days |
Cross-checks touching this measure FROM THE FILING REVIEW
◐ PARTLYCMS revenue concentration
The quoted figures do not map one-for-one onto a filed line on this page; carried as partly supported.
FY2025 10-K · FULL RECONCILIATION →◐ PARTLYrevenue growth
1 of 3 quoted figures reconcile (12% against total revenues); 16%, 7% does not map to a filed line on this page — carried as partly supported.
FY2025 10-K · FULL RECONCILIATION →✓ CLEANReceivables pace
Days sales outstanding moved -1.6 days — inside the ±7-day watch threshold.
FY2025 10-K · FULL RECONCILIATION →✓ CLEANInventory vs revenue pace
Inventory moved -13.2%, revenue +11.8% (gap -25.0pp). The flag tests inventory OUTRUNNING revenue by more than 7pp.
FY2025 10-K · FULL RECONCILIATION →More SAME DATA, OTHER VIEWS
Days sales outstanding across coverage → · UNH company view →
Revenue · Net income · Operating cash flow · Free cash flow · Capital expenditure · Cash & equivalents · Total assets · Shareholders' equity · Total debt · Return on equity
Not investment advice. Every figure on this page is an XBRL fact from the issuer's own SEC filings or an arithmetic over such facts with the method shown. No forecast is made; no posture is expressed.